Canigen®DHPPi
Canigen®DHPPi is a modified, live vaccine for puppies and dogs
For the active immunisation of healthy puppies and dogs against canine distemper, contagious hepatitis, parvovirus infection and respiratory disease caused by canine parainfluenza virus.
FOR ANIMAL USE ONLY
Only for use by persons authorised thereto in terms of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).
Composition: Canigen DHPPi Freeze-dried component: Attenuated canine distemper virus, attenuated canine adenovirus type 2, attenuated parvovirus and attenuated canine parainfluenza virus. Sterile diluent: Sterile water for injection.
Warnings:
- Vaccinate healthy dogs only.
- Vaccination of pregnant or lactating bitches is not recommended.
- Occasional hypersensitivity reactions may be observed in some animals. Immediate treatment for anaphylactic shock (adrenaline, antihistamines and corticosteroids) must be given.
- Do not administer any corticosteroids or antiviral drugs preceding or following vaccination.
- Some dogs may be unable to develop or maintain an adequate immune response after vaccination due to various factors, such as incubating infectious disease, malnourishment, parasite infestation, or stress.
- Keep out of reach of children and uninformed persons.
- Although this vaccine has been extensively tested under a wide variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, contact the registration holder.
Precautions:
- It is recommended that animals be treated for external and internal parasites at least 10 days prior to vaccination.
- The vaccine should be administered in accordance with standard aseptic conditions for vaccination.
- Avoid exposure of the animal to infection for 21 days following vaccination.
- Use the vaccine immediately following reconstitution.
- Used needles, syringes and vials should be disposed of in a safe manner.
Directions for use: Use only as directed.
The vial containing the freeze-dried Canigen DHPPi component should be reconstituted with 1 ml of the sterile diluent. Shake well. Administer 1 ml subcutaneously.
Primary vaccination: Puppies can be vaccinated from 8 weeks of age with 1 dose of Canigen DHPPi, followed by a second dose 3 weeks later.
Booster vaccination: Annual revaccination with a single dose of Canigen DHPPi.
High-risk situations: Canigen DHPPi can be administered in puppies from 6 weeks of age under circumstances- where the risks of parvovirus and distemper may be higher.
Virbac recommends the following standard vaccination protocol under normal circumstances:
Canigen DHPPi at 8 weeks of age
Canigen DHPPi/L at 11 weeks of age
Canigen DHPPi/LR at 14 weeks of age
Virbac recommends the following vaccination protocol in high-risk areas:
Canigen DHPPi at 6 weeks of age
Canigen DHPPi/L at 9 weeks of age
Canigen DHPPi/LR at 12 weeks of age
Presentation: 25 single-dose vials of freeze-dried Canigen DHPPi component and 25 vials of sterile diluent packed in a plastic container with package insert enclosed.
Storage instructions: Store at 2-8 °C. Protect from light. Do not freeze.
Registration Numbers:
South Africa Reg. No: G2901 (Act 36/1947).
Namibia Reg. No: V06/24.1/916 NS2
